Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 16 Issue 3, March 2019

In this Issue Stephen Fry and Ben Challacombe discuss the patient and the surgeon view of prostate cancer.

Image of prostate cancer patient-derived organoids supplied by Hatem Sabaawy, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.

Editorial

  • Understanding the disparities between a surgeon and patient experience is valuable for both. And what patient is better placed to describe their prostate cancer journey than Stephen Fry?

    Editorial

    Advertisement

Top of page ⤴

Comment

  • Despite initial enthusiasm, poor translation of preclinical studies and high-profile scandals involving stem cell research have hindered the field of regenerative urology in recent years. However, consideration of the potential of regenerative approaches to revolutionize patient care ought to reignite interest and begin a renaissance in regenerative urology research.

    • Margot S. Damaser
    • Karl-Dietrich Sievert
    Comment
Top of page ⤴

Research Highlights

Top of page ⤴

News & Views

  • A large genomic study of upper tract urothelial carcinoma and bladder tumours reveals differences in mutational frequencies and demonstrates a clonal relationship between paired tumours. In addition to these genomic insights, a combined tumour and germline genetic analysis approach is suggested to improve the identification of patients with Lynch syndrome.

    • Lars Dyrskjøt
    News & Views
  • The long-term outcomes of the first prospective, multi-institutional, single-arm study of patients with prostate cancer treated with salvage radical prostatectomy after disease recurrence following radiotherapy have recently been published. Durable oncological control was reported, possibly because most patients had low-risk or intermediate-risk prostate cancer at initial diagnosis and the biochemical progression-free survival interval was long.

    • Gaëtan Devos
    • Steven Joniau
    News & Views
Top of page ⤴

Viewpoint

Top of page ⤴

Reviews

  • In this Review, the authors describe technologies for image-guided surgery for managing lymphatic metastases in prostate cancer. Refining these technologies should increase precision in the surgical recognition of positive lymph nodes and reduce the morbidity of pelvic lymph node dissection.

    • Fijs W. B. van Leeuwen
    • Alexander Winter
    • Tobias Maurer
    Review Article
  • Nonoperative management is the only treatment option for Peyronie’s disease in the acute phase of the disease, when surgery is contraindicated. In this Review, Tsambarlis and Levine discuss the oral and topical therapies that have been shown to be efficacious and provide recommendations for their use.

    • Peter Tsambarlis
    • Laurence A. Levine
    Review Article
  • This Review describes the key insights into urologic chronic pelvic pain syndrome (UCPPS) from the first phase of Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network studies and highlights their implications for understanding the pathophysiological basis and clinical management of UCPPS.

    • J. Quentin Clemens
    • Chris Mullins
    • J. Richard Landis
    Review Article
Top of page ⤴

Correspondence

Top of page ⤴

Search

Quick links